Expand the success of screening to reduce aortic aneurysm mortality: progress interpretation and new fronts

By sjmartinez • May 6, 2025

Zong NC, Huang K, Yang X, Cai H. Expand the success of screening to reduce aortic aneurysm mortality: progress interpretation and new fronts. Trends Cardiovasc Med. 2025 May;35(4):221-229. doi: 10.1016/j.tcm.2024.12.004. Epub 2024 Dec 13. PMID: 39675687.

Tags: abdominal aortic aneurysm, Biomarker, Cardiology/Epi, cost-effectiveness, diagnostics, EVAR, mortality, Preventative medicine, Publications, screening, smoking, surveillance, thoracic aortic aneurysm, ultrasonography, USPST

Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression

Chen J, Zhou Q, Su L, Ni L. Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression. Ren Fail. 2025 Dec;47(1):2506812. doi: 10.1080/0886022X.2025.2506812. Epub[...]

Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers

Packard RRS, Pelletier-Galarneau M, Malhotra S, Dorbala S, Chen W, Dilsizian V. Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers. JACC Cardiovasc Imaging. 2025 May 13:S1936-878X(25)00173-1.[...]

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective

Wilkinson MJ, Bijlani P, Davidson MH, Duell PB, Horan M, Malloy MJ, Newfield RS, Pradeep P, Shah PK, Stock EO, Warden BA, Ito MK. Real-World[...]